CSIMarket
 
Prometheus Biosciences Inc   (NASDAQ: RXDX)
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 47
 Employees 143
 Revenues (TTM) (Millions $) 4
 Net Income (TTM) (Millions $) -151
 Cash Flow (TTM) (Millions $) -149
 Capital Exp. (TTM) (Millions $) 2

Business Description


Prometheus Biosciences Inc is a biotechnology company focused on developing and commercializing precision therapeutics and companion diagnostics for immune-mediated diseases. The company's goal is to improve patient outcomes by providing personalized treatments that target the specific molecular and cellular mechanisms of these diseases. Prometheus Biosciences utilizes cutting-edge technologies and scientific expertise to identify and develop innovative therapies, with an emphasis on inflammatory bowel disease (IBD) and other autoimmune diseases. They work in collaboration with academic institutions, research organizations, and pharmaceutical companies to accelerate the discovery and development of precision medicines.


   Company Address: 3050 Science Park Road San Diego 92121 CA
   Company Phone Number: 422-4300   Stock Exchange / Ticker: NASDAQ RXDX


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ABBV   -1.39%    
BMY   -0.59%    
JNJ        2.53% 
LLY   -0.68%    
MRK   -0.8%    
PFE        2.08% 
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 36.9
Working Capital Ratio 37.56
Leverage Ratio (MRQ) 0.09
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -3.57 $
Revenues (TTM) 0.08 $
Cash Flow (TTM) -
Cash 15.04 $
Book Value 14.7 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 27,937
Net Income per Employee (TTM) -1,052,881
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.01

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -4407.6 %
Net Margin (MRQ) -3699.19 %
Net Cash Flow Margin (MRQ) -19388.87 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.